The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...

Results of this phase III trial demonstrated that stapokibart rapidly, significantly, and sustainably controlled both nasal and ocular symptoms in patients with moderate-to-severe SAR, while markedly ...

I recently went to A&E with a very high temperature. I had my blood taken and was told that my troponin levels are 4,000.

A laryngologist explains the surprising causes of chronic throat clearing, including silent reflux, allergies and muscle memory. Learn expert strategies to break the cycle and protect vocal health.

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

The study results demonstrate the ability to improve the sense of smell with noninvasive devices in different types of users.

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...